XML 64 R53.htm IDEA: XBRL DOCUMENT v3.19.1
Related Parties Transactions (Details)
3 Months Ended
Mar. 31, 2019
BioFirst Corporation (the "BioFirst") [Member]  
Relationship with the Company and its subsidiaries, description Entity controlled by controlling beneficiary shareholder of Yuangene
BioFirst (Australia) Pty Ltd. (the "BioFirst (Australia)") [Member]  
Relationship with the Company and its subsidiaries, description 100% owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene
Lion Arts Promotion Inc. (the "LION") [Member]  
Relationship with the Company and its subsidiaries, description Controlling shareholder of BioLite Inc.
LionGene Corporation (the "LionGene") [Member]  
Relationship with the Company and its subsidiaries, description Shareholder of the Company; entity controlled by controlling beneficiary shareholder of YuanGene
Rgene Corporation (the "Rgene") [Member]  
Relationship with the Company and its subsidiaries, description Shareholder of the Company; entity controlled by controlling beneficiary shareholder of Yuangene
Yuangene Corporation (the "Yuangene") [Member]  
Relationship with the Company and its subsidiaries, description Controlling beneficiary shareholder of the Company
AsianGene Corporation (the "AsianGene") [Member]  
Relationship with the Company and its subsidiaries, description Shareholder; entity controlled by controlling beneficiary shareholder of Yuangene
Keypoint Technology Ltd. (the "Keypoint') [Member]  
Relationship with the Company and its subsidiaries, description The Chairman of Keypoint is Eugene Jiang's mother.
Yoshinobu Odaira (the "Odaira") [Member]  
Relationship with the Company and its subsidiaries, description Director of the Company
GenePharm Inc. (the "GenePharm") [Member]  
Relationship with the Company and its subsidiaries, description Mr. George Lee, the Director and Chairman of Biokey, is the Chairman of Genepharm.
Mr. Tsung-Shann Jiang, Ms. Shu-Ling Jiang and Mr. Eugene Jiang (the "Jiangs")  
Relationship with the Company and its subsidiaries, description Mr. Tsung-Shann Jiang, the controlling beneficiary shareholder of the Company and Rgene, the chairman and CEO of the BioLite Inc. and the President and a member of board of directors of BioFirst,